SCHEMBL21762771

SCHEMBL21762771

CNCC(=O)NCCOCCN

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CA2 P00918 8/20 0.39
CA1 P00915 7/20 0.39
CA12 O43570 4/20 0.33
CA4 P22748 4/20 0.33
CA9 Q16790 4/20 0.33
CA14 Q9ULX7 4/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ADRB2 P07550 1/20 0.32
HTR1A P08908 1/20 0.32
TLR2 O60603 1/20 0.32
TSHR P16473 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
ADORA3 P0DMS8 1/20 0.31
LMNA P02545 1/20 0.31
SLC6A5 Q9Y345 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13311547 0.88 MEN1 (0.48) MEN1KMT2ACA2CA1CA12
SCHEMBL14274646 0.84 PAOX (0.40) MEN1KMT2ACA2CA1CA12
SCHEMBL19133112 0.83 EPHX2 (0.43) MEN1KMT2ACA2CA1ALDH1A1
SCHEMBL8956669 0.81 MEN1 (0.39) MEN1KMT2ACA2CA1CA12
SCHEMBL16081529 0.81 MEN1 (0.39) MEN1KMT2ACA2CA1CA12
SCHEMBL24307290 0.81 TSHR (0.43) MEN1KMT2ACA2CA1ALDH1A1
SCHEMBL17860028 0.81 MEN1 (0.50) MEN1KMT2ACA2CA1CA12
SCHEMBL12402012 0.81 EPHX2 (0.41) MEN1KMT2ACA2CA1ALDH1A1
SCHEMBL14563091 0.81 TSHR (0.40) CA2CA1ALDH1A1TLR2TSHR
SCHEMBL16081648 0.80 MEN1 (0.42) MEN1KMT2ACA2CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898630-B1 NOVEL IMIDAZOPYRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2023-05-10 EP disclosed
CN-113195498-A Novel imidazopyrazine derivatives 豪夫迈·罗氏有限公司 2021-07-30 CN disclosed
WO-2020041169-A2 INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION JANSSEN PHARMACEUTICA NV (BE) 2020-02-27 WO disclosed